Series A - Aerie Pharmaceuticals
Investment Firm
Overview
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company developing products for the treatment of glaucoma.
Announced Date
Oct 11, 2005
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 TPG Biotech |
Round Details and Background
Aerie Pharmaceuticals raised $10000000 on 2005-10-11 in Series A
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company developing products for the treatment of glaucoma.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 09, 2014 |  Post-IPO Equity - Aerie Pharmaceuticals | 1 | - | 125.0M |
| Sep 01, 2010 | Debt Financing - Aerie Pharmaceuticals | - | 5.3M | |
| Aug 29, 2013 | Debt Financing - Aerie Pharmaceuticals | - | 15.0M | |
| Mar 07, 2011 | Series B - Aerie Pharmaceuticals | 5 | - | 41.4M |
Recent Activity
There is no recent news or activity for this profile.